Category - Executive Moves

Executive Moves

Theralase names Roger DuMoulin-White as president and CEO

Theralase Technologies (TSXV:TLT; OTCQB:TLTFF) appointed Roger DuMoulin-White as president and CEO, succeeding Arkady Mandel, M.D., Ph.D., as interim CEO. Dr. Mandel will continue as CSO and a director. Mr. DuMoulin...

May 25, 2023

Executive Moves

Conavi Medical names CV device veteran Brian Chambless as CCO

Conavi Medical appointed accomplished cardiovascular medical device industry veteran, Brian Chambless, to the newly created position of chief commercial officer (CCO). In an executive management career spanning more...

May 15, 2023

Executive Moves

PharmaJet names Nathalie Landry as CSO

PharmaJet appointed Nathalie Landry as chief scientific officer to provide strategic leadership and ensure the company’s clinical and scientific programs align with its global commercial expansion. PharmaJet’s pipeline...

May 2, 2023

Executive Moves

Jeffrey Dayno named president, CEO of Harmony Biosciences

Harmony Biosciences (NASDAQ:HRMY) appointed Jeffrey Dayno, M.D., as president and CEO, and a member of the board. Dr. Dayno, a nationally recognized neuroscience expert, joined Harmony as CMO and EVP when the company...

April 24, 2023

Executive Moves

IntelGenx makes organizational changes to support global growth strategy

IntelGenx Technologies (TSX:IGX; OTCQB:IGXT) appointed Dwight Gorham as CEO, effective immediately, succeeding the company’s founder, Horst Zerbe, Ph.D., who has retired as CEO, but will continue as chairman. The CEO...

April 13, 2023

Executive Moves

NervGen appoints Michael Kelly as president, CEO

NervGen Pharma (TSXV:NGEN; OTCQX:NGENF) named Michael Kelly to the position of president and CEO, effective April 10, as well as a member of the board. In a statement, Bill Radvak, executive chairman of NervGen, said Mr...

April 10, 2023

Executive Moves

Hepion expands SAB with appointments of four liver disease KOLs

Hepion Pharmaceuticals (NASDAQ:HEPA) added four new internationally recognized thought leaders to its scientific advisory board (SAB), effective immediately. These new members, who bring decades of liver disease...

March 30, 2023

Executive Moves

OpSens names John Hannigan as CFO

OpSens (TSX:OPS; OTCQX:OPSSF) appointed John Hannigan as CFO, effective immediately. Mr. Hannigan is a highly experienced financial executive with more than 22 years of proven financial expertise with domestic and...

March 27, 2023

Executive Moves

Dylan Dupuis joins ROTH MKM healthcare research team

Dylan Dupuis, Ph.D., has joined ROTH MKM’s healthcare research team as managing director, senior research analyst covering biotechnology. His research coverage is expected to include micro-cap and small-cap...

March 13, 2023

Executive Moves

Heron names renowned healthcare investor Kevin Kotler to the board

Heron Therapeutics (NASDAQ:HRTX) appointed three new directors to the board, including Kevin Kotler, a renowned healthcare investor, founder and portfolio manager of Broadfin Capital. Mr. Kotler has over 30 years of...

February 24, 2023

Category - Executive Moves

Theralase names Roger DuMoulin-White as president and CEO

Conavi Medical names CV device veteran Brian Chambless as CCO

PharmaJet names Nathalie Landry as CSO

Jeffrey Dayno named president, CEO of Harmony Biosciences

IntelGenx makes organizational changes to support global growth strategy

NervGen appoints Michael Kelly as president, CEO

Hepion expands SAB with appointments of four liver disease KOLs

OpSens names John Hannigan as CFO

Dylan Dupuis joins ROTH MKM healthcare research team

Heron names renowned healthcare investor Kevin Kotler to the board

General

More